BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7508989)

  • 1. Studies on primer binding of HIV-1 reverse transcriptase using a fluorescent probe.
    Delahunty MD; Wilson SH; Karpel RL
    J Mol Biol; 1994 Feb; 236(2):469-79. PubMed ID: 7508989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of human immunodeficiency virus type 1 reverse transcriptase primer tRNA binding by fluorescence spectroscopy: specificity and comparison to primer/template binding.
    Thrall SH; Reinstein J; Wöhrl BM; Goody RS
    Biochemistry; 1996 Apr; 35(14):4609-18. PubMed ID: 8605212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 reverse transcriptase shows no specificity for the binding of primer tRNA(Lys3).
    Arion D; Harada R; Li X; Wainberg MA; Parniak MA
    Biochem Biophys Res Commun; 1996 Aug; 225(3):839-43. PubMed ID: 8780699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primer selection by HIV-1 reverse transcriptase on RNA-tRNA(3Lys) and DNA-tRNA(3Lys) hybrids.
    Yusupova G; Lanchy JM; Yusupov M; Keith G; Le Grice SF; Ehresmann C; Ehresmann B; Marquet R
    J Mol Biol; 1996 Aug; 261(3):315-21. PubMed ID: 8780773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural constraints in the HIV-1 reverse transcriptase-primer/template complex for the initiation of DNA synthesis from primer tRNALys3.
    Zakharova OD; Martiyanov IV; Timofeeva OA; Kolocheva TI; Fournier M; Andreola ML; Maksakova GA; Yamkovoy VI; Litvak S; Tarrago-Litvak L; Nevinsky GA
    Biochemistry; 1998 Sep; 37(38):13343-8. PubMed ID: 9748342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse transcriptase of human immunodeficiency virus can use either human tRNA(3Lys) or Escherichia coli tRNA(2Gln) as a primer in an in vitro primer-utilization assay.
    Kohlstaedt LA; Steitz TA
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9652-6. PubMed ID: 1384059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linked lexitropsins and the in vitro inhibition of HIV-1 reverse transcriptase RNA-directed DNA polymerization: a novel induced-fit of 3,5 m-pyridyl bisdistamycin to enzyme-associated template-primer.
    Filipowsky ME; Kopka ML; Brazil-Zison M; Lown JW; Dickerson RE
    Biochemistry; 1996 Dec; 35(48):15397-410. PubMed ID: 8952492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of methionine 184 of human immunodeficiency virus type-1 reverse transcriptase in the polymerase function and fidelity of DNA synthesis.
    Pandey VN; Kaushik N; Rege N; Sarafianos SG; Yadav PN; Modak MJ
    Biochemistry; 1996 Feb; 35(7):2168-79. PubMed ID: 8652558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic studies comparing the incorporation of (+) and (-) isomers of 3TCTP by HIV-1 reverse transcriptase.
    Feng JY; Anderson KS
    Biochemistry; 1999 Jan; 38(1):55-63. PubMed ID: 9890882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3,5,8-Trihydroxy-4-quinolone, a novel natural inhibitor of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
    Loya S; Rudi A; Tal R; Kashman Y; Loya Y; Hizi A
    Arch Biochem Biophys; 1994 Mar; 309(2):315-22. PubMed ID: 7510944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of RNA secondary structure on the kinetics of DNA synthesis catalyzed by HIV-1 reverse transcriptase.
    Suo Z; Johnson KA
    Biochemistry; 1997 Oct; 36(41):12459-67. PubMed ID: 9376350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance.
    Tantillo C; Ding J; Jacobo-Molina A; Nanni RG; Boyer PL; Hughes SH; Pauwels R; Andries K; Janssen PA; Arnold E
    J Mol Biol; 1994 Oct; 243(3):369-87. PubMed ID: 7525966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of glutamine-151 of human immunodeficiency virus type-1 reverse transcriptase in RNA-directed DNA synthesis.
    Kaushik N; Harris D; Rege N; Modak MJ; Yadav PN; Pandey VN
    Biochemistry; 1997 Nov; 36(47):14430-8. PubMed ID: 9398161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the nucleotide binding properties of SV40 T antigen using fluorescent 3'(2')-O-(2,4,6-trinitrophenyl)adenine nucleotide analogues.
    Huang SG; Weisshart K; Fanning E
    Biochemistry; 1998 Nov; 37(44):15336-44. PubMed ID: 9799494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A drug resistance mutation in the inhibitor binding pocket of human immunodeficiency virus type 1 reverse transcriptase impairs DNA synthesis and RNA degradation.
    Fan N; Rank KB; Slade DE; Poppe SM; Evans DB; Kopta LA; Olmsted RA; Thomas RC; Tarpley WG; Sharma SK
    Biochemistry; 1996 Jul; 35(30):9737-45. PubMed ID: 8703945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the interactions of HIV1 replication primer tRNA(Lys,3) with nucleocapsid protein and reverse transcriptase.
    Barat C; Schatz O; Le Grice S; Darlix JL
    J Mol Biol; 1993 May; 231(2):185-90. PubMed ID: 7685391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the inhibition of human immunodeficiency virus type 1 reverse transcriptase DNA polymerase activity by analogs of nevirapine and [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro-5"-(4"-amino-1", 2"-oxathiole-2",2"-dioxide] (TSAO).
    Arion D; Fletcher RS; Borkow G; Camarasa MJ; Balzarini J; Dmitrienko GI; Parniak MA
    Mol Pharmacol; 1996 Nov; 50(5):1057-64. PubMed ID: 8913335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific initiation and switch to elongation of human immunodeficiency virus type 1 reverse transcription require the post-transcriptional modifications of primer tRNA3Lys.
    Isel C; Lanchy JM; Le Grice SF; Ehresmann C; Ehresmann B; Marquet R
    EMBO J; 1996 Feb; 15(4):917-24. PubMed ID: 8631312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity labeling and functional analysis of the primer binding domain of HIV-1 reverse transcriptase.
    Andreola ML; Tarrago-Litvak L; Levina AS; Kolocheva TI; el Dirani-Diab R; Jamkovoy VI; Khalimskaya NL; Barr PJ; Litvak S; Nevinsky GA
    Biochemistry; 1993 Apr; 32(14):3629-37. PubMed ID: 7682110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence studies on the nucleotide binding domains of the P-glycoprotein multidrug transporter.
    Liu R; Sharom FJ
    Biochemistry; 1997 Mar; 36(10):2836-43. PubMed ID: 9062112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.